Lumonus

North Sydney, Australia

Lumonus is a healthcare company that offers Radiation Oncology, Radiation Therapy, and Cancer treatment technology-enabled services.

$16.3M raised

Nov 2025

Series B

Top Investors

Oncology VenturesAviron Investment Management

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Lumonus raised?

Lumonus has raised $16.3M in total funding. The most recent round was Series B. The last funding was announced in November 2025.

Who are Lumonus's investors?

Lumonus's investors include Oncology Ventures, Aviron Investment Management.

Where is Lumonus headquartered?

Lumonus is headquartered in North Sydney, Australia.

What does Lumonus do?

Lumonus is a healthcare company that offers Radiation Oncology, Radiation Therapy, and Cancer treatment technology-enabled services.

What stage is Lumonus at?

Lumonus is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 6, 2025.

MLA

"Lumonus — Funding & Investors." VCBacked, November 6, 2025, https://www.vcbacked.co/company/lumonus. Accessed June 4, 2026.

APA

VCBacked. (2025). Lumonus — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/lumonus

Wikipedia (cite web)

{{cite web |title=Lumonus — Funding & Investors |url=https://www.vcbacked.co/company/lumonus |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 6, 2025.